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Lethal infantile mitochondrial disease 
with isolated complex I deficiency in 
fibroblasts but with combined complex I 
and IV deficiencies in muscle
H.A.C.M. Bentlage, MSc; U. Wendel, MD; H. Schägger, PhD; H .J. ter Laak, PhD; A.J.M. Janssen, BSc; and
J.M.F. Trijbels, PhD
Article abstract—A 2-month-old boy died of a lethal infantile mitochondrial disease with severe lactic acidosis and 
involvement of the CNS. Histochemical analysis of skeletal muscle showed that cytochrome c oxidase staining was lacking 
in all muscle fibers but was present in arterioles. Ragged red fibers were not seen, but some fibers showed excessive 
staining for succinate dehydrogenase. Biochemical analysis revealed a combined complex I and IV deficiency in skeletal 
muscle but only a complex I deficiency in his fibroblasts. Two-dimensional native SDS electrophoresis confirmed these 
enzymatic findings at the protein level. Analysis of mitochondrial translation products in fibroblasts revealed no abnor­
malities, and analysis of mitochondrial DNA in muscle showed no depletion, large-scale deletions, or frequently occurring 
point mutations. We conclude that this disease must have been the result of either a nuclear DNA mutation in a gene 
controlling the expression or assembly of both complex I and the muscle-specific isoform of complex IV or, alternatively, a 
heteroplasmic point mutation in a mitochondrial tRNA, which codon is used more often by mtDNA encoded subunits of 
complex I than by mtDNA encoded subunits of complex IV. A different degree of heteroplasmy in skeletal muscle and 
fibroblasts would then explain the curious heterogeneous tissue expression of defects in this patient.
NEUROLOGY 1996;47:243-248
Mitochondrial encephalomyopathies are a heteroge­
neous group of disorders in which various tissues are 
affected, predom inantly skeletal muscle and the 
CNS.1 The primary cause of disease is thought to be 
a defect in the mitochondrial energy metabolism. 
The five enzyme complexes (complexes I to V) of oxi­
dative phosphorylation (OXPHOS) play a crucial role 
in this ATP-generating system. Each mitochondrion 
contains its own mitochondrial DNA (mtDNA), 
which is maternally inherited. The mtDNA encodes 
seven subunits of NADH:ubiquinone oxidoreductase 
(complex I), one subunit of ubiquinolxytochrome c 
oxidoreductase (complex III), three subunits of cyto­
chrome c oxidase (COX) (complex IV), two subunits 
of ATP synthase (complex V), two ribosomal RNAs, 
and 22 transfer RNAs necessary for mtDNA gene 
expression.2 The genes of complexes I, III, IV, and V 
are located in both the mtDNA and the nuclear DNA 
(nDNA). Succinate :ubiquinone oxidoreductase (com­
plex II) contains only nDNA encoded subunits. All 
nDNA encoded subunits are imported into the mito­
chondria where they are assembled together with 
the mtDNA encoded subunits. Deficiencies in com­
plex I and complex IV, either alone or combined, are 
found most frequently .3'6
A growing number of mitochondrial encephalo-
myopathies or other neurologic disorders have been 
associated with deletions, depletions, or more than  
30 point m utations in the mtDNA .7 These m utations 
are often found only in a proportion of the mtDNA 
molecules (heteroplasmy). Also, nDNA m utations af­
fecting OXPHOS are expected to cause these dis­
eases but have not been described so far.
We present a pa tien t who immediately after b irth  
had a severe lactic acidosis. Biochemical analysis re­
vealed a combined deficiency of complex I and IV in 
muscle tissue but only an isolated complex I defi­
ciency in fibroblasts.
Case report. A boy was born by normal delivery after an 
uncomplicated 39-week pregnancy. Birth weight was 3,680 
g, length was 54.5 cm, and head circumference was 35 cm. 
His unrelated parents and a 4-year-old sister are in good 
health.
Within 18 hours after birth, the baby became tachyp- 
noeic and developed an overwhelming lactic acidosis (blood 
pH 7 .02, base excess —25.3 mmol/L, blood lactate 88 to 147 
mg/dL [normal <16 mg/dL] and pyruvate 1.13 mg/dL [nor­
mal <0.59 mg/dL]). There were no signs of an infection. 
Plasma amino acid analysis revealed hyperalaninemia. Re­
peated urine analysis showed variable increased excretion
of lactate, ethylmalonate, and 3-hydroxybutyrate. In CSF,
i
lactate was elevated (42 mg/dL; normal 1 1  to 19 mg/dL).
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Despite continuous buffering, severe acidotic periods re­
curred. Gradually, a developmental delay, hypertonicity, 
and occasionally seizures occurred (signs of CNS involve­
ment).
Because of suspicion for a mitochondrial disorder, a sur­
gical muscle biopsy of the quadriceps was performed at age 
29 days. During this time, blood lactate was 230 mg/dL 
and pyruvate was 3.52 mg/dL. Multivitamin therapy was 
started thereafter. A biopsy of the skin was taken at age 42 
days. When the child was 58 days old, his condition sud­
denly worsened and he died from respiratory and cardiac 
arrest. Autopsy was not allowed.
M ethods. Histologic an d  electron microscopic analysis. 
Light microscopy, histologic stains, and electron micros­
copy of the muscle biopsy were done according to standard 
procedures.
Biochemical analysis  o f  muscle tissue. The oxidation 
rates of radiolabeled substrates (pyruvate, malate, and 
succinate), the ATP + creatine phosphate (CrP) production 
rates from pyruvate and succinate, and the mitochondrial 
enzyme activities were measured in 600 g  supernatant of 
muscle homogenates as described previously.9 Control 
specimens were considered those patients, ages 4 to 56 
years, in which a mitochondrial defect had been excluded 
by substrate oxidation rates and individual enzyme mea­
surements comparable with persons having restorative 
surgery. Complex III activity was measured using decylu- 
biquinol and horse heart cytochrome c (both Sigma) as 
substrates according to Zheng et al.f> Tween 20 (0.04% v/v) 
was added to the assay mixture to reduce the nonenzymic 
reaction. All biochemical values are expressed per mU ci­
trate synthase (CS) to correct for mitochondrial recovery in 
the 600 g  supernatant of muscle or in the mitochondria- 
enriched fraction of fibroblasts (see below).
F ibrob las t  s tudies. Human skin fibroblasts were 
grown in M199 (GIBCO) medium supplemented with 20% 
(v/v) fetal calf serum. Control specimens were obtained 
from healthy volunteers. Enzyme activities were measured 
in mitochondria-enriched fractions, which were prepared 
as described previously10 with the following modifications. 
Approximately 20 X 106 cells were homogenized in 10 mM 
Tris • HC1 (pH 7.6), thereafter adjusted to 0.25 M sucrose 
and subsequently differentially centrifuged (600 g  and
14,000 g). The formation of lactate and pyruvate from glu­
cose was determined in monolayer grown fibroblasts as 
described, 11 except that fibroblasts were cultured in M199 
medium.
Two-dimensional electrophoi'esis. The amounts of as­
sembled OXPHOS enzymes in muscle homogenate (20 mg) 
or frozen fibroblasts (4 X 106 cells) were quantitated by 
two-dimensional polyacrylamide gel electrophoresis 
(PAGE) (blue native/Tricine-SDS-PAGE) and subsequent 
densitometric analysis of Coomassie stained gels.6
M itochondrial protein  synthesis. Mitochondrial trans­
lation products of fibroblasts from the patient and two 
control subjects were labeled in near confluent six-well 
plates (diameter 1 cm) for 2 hours with [35Slmethionine 
(0.4 mCi/mL; 1,200  Ci/mmol) in the presence of emetine, 
an inhibitor of cytoplasmic protein synthesis, at 100  jxg/ 
mL.12 After the labeling, the cells were washed twice with 
phosphate-buffered saline (pH 7.4) and detached by treat­
ment with trypsin. Cells were lysed in 10  mM Tris * HC1 
(pH 7.4) with 0.1% (w/v) SDS. Equal amounts of cell ly­
sates (20 jxg per lane) were analyzed on 16.5% minislab 
gels13 and prepared for fluorography.14
MtDNA analysis. MtDNA was analyzed in total DNA 
isolated from muscle as reported previously. 15 The mtDNA 
content in muscle tissue was quantitated by Southern blot­
ting analysis using probes for the total mtDNA and the 
nuclear 18S rDNA gene. Control specimens were obtained 
from patients aged 4 to 56 years.
Results. Histochemistry and electron microscopy. Mor­
phologic examination of the patients skeletal muscle re­
vealed no ragged red fibers, but the staining for succinate 
dehydrogenase (SDH) showed a few large fibers with ex­
ceptionally high activity (figure 1, A and B). COX activity 
was absent in all muscle fibers but was present in smooth 
muscle cells of arterioles (figure 1, C and D). There was no 
glycogen or lipid accumulation. Electron microscopy re­
vealed no structural abnormalities of the mitochondria.
Biochemical studies. Biochemical investigation in 
fresh skeletal muscle 600 g  supernatant revealed that oxi­
dation rates and ATP 4- CrP production rates with pyru­
vate, malate, and succinate as substrates were all signifi­
cantly diminished (p <  0.05; table 1 ). Complex IV activity 
was most severely decreased (11% of the mean of control 
subjects; p  <  0.05). The activities of NADH:QX oxidoreduc­
tase (complex I) was decreased 24% of the mean of control 
subjects and NADH:02 oxidoreductase (complexes I -I- III 
+ IV) were also decreased 27% of the mean of control 
subjects. Complex III and other enzyme  activities were 
nearly normal (see table 1 ).
In the patient’s fibroblasts, on the contrary, complex IV 
activity was in the normal range, both in whole cell homog­
enate and in the mitochondria enriched fraction (table 2), 
Here, only complex I activity was significantly decreased 
(39% of the mean of control subjects; p  <  0.05). An in­
creased lactate-pyruvate ratio after glucose conversion in 
these cells (42, normal <25) pointed also toward a respira­
tory chain defect.
Two-dimensional electrophoresis. Analysis of muscle 
homogenate of the patient showed that both complex I and 
IV were nearly absent (figure 2). Complex I could not be 
detected, even by more sensitive silver staining of the gels. 
Densitometric analysis of Coomassie stained gels revealed 
that the amount of correctly assembled complex IV was 
decreased (23% of the mean control subject concentration). 
Complex I was below the detection limit (i.e., less than 
20% of the mean control subject concentration). Complex 
III and V were present in normal amounts, whereas the 
complex II amount (visible after silver staining, results not 
shown) was slightly increased. In fibroblasts of the patient, 
normal amounts of assembled complexes II, III, TV, and V 
were detected (results not shown). Complex I is very diffi­
cult to detect in fibroblasts, even in control subjects.
Mitochondrial protein synthesis, Metabolic labeling of 
the patient fibroblasts revealed that all detectable mito­
chondrial translation products were present in amounts 
equal to two control subjects (figure 3).
MtDNA analysis. Investigation of mtDNA in the pa­
tients muscle revealed no mtDNA depletion, large dele­
tions, or point mutations, which are frequently associated 
with mitochondrial encephalomyopathy, lactic acidosis, 
and stroke-like episodes (MELAS, position 3248); myo­
clonic epilepsy and ragged red fiber disease (position
244 NEUROLOGY 47 July 1996
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Oxidation rate (nmol/hr/mU CS)
[ l-14C]Pyruvate -l- malate 0.60 (1 1 ) 5.52 ± 0.99 14
(3.61--7.48)
[U-14C]Malate 4- pyruvate + 1.16 (16) 7.18 ± 1.28 20
maionate (4.68-■9.62)
ATP + CrP production rate
(nmol/hr/mD CS)
Pyruvate + malate 5.8 (9) 63.9 ± 10.1 16
(42.1--81.2)
Succinate 4- acetyl carnitine 5.3 (40) 13.1 ± 3.7 13
(7.2-:18.4)
Activity (mU/mU CS)
NADH’.Qj oxidoreductase 0.036 (24) 0.153 ± 0.061 21
(0.061-■0.276)
Succinate;cytochrome c 0.41 (78) 0.56 ± 0.13 26
oxidoreductase (0.31-■0.84)
Decylubiquinohcytochrome c 2.78 (62) 4.52 ± 0.99 16
oxidoreductase (2.85- 6.61)
Cytochrome c oxidase 0.19 (1 1 ) 1.78 ± 0.61 28
(0.81-•3.13)
NADH:02 oxidoreductase 0.12 (27) 0.44 ± 0.14 20
(0.28--0.84)
Pyruvate dehydrogenase^ 0.051 (63) 0.081 ± 0.024 25
(0.034--0.122)
CS (mU/mg protein) 67 (64) 104 ± 29 28
(65- 162)
* Percent of mean of controls.
t  Values are means ±  SD, range in parentheses.
$ In homogenate,
CS = citrate synthase.
ment, and we found a normal complex I activity in 
fibroblasts of the second case .19
There are previous reports on heterogeneous tis­
sue expression of OXPHOS defects in mitochondrial 
encephalomyopathies.20*22 In some cases, this was as- 
sociated w ith mtDNA depletion21 or the MELAS 
3243 m utation ,22 Both m utations were excluded in 
our patient. We examined fibroblasts of 10 other pa­
tients w ith combined complex I and TV defects in 
muscle tissue, including some previously reported ,5*20 
and found only in  one case a complex IV defect. All 
other fibroblasts did not show a respiratory chain 
enzyme defect. We dem onstrated an isolated complex 
I deficiency also in fibroblasts of eight other patients, 
most of them  having LIMD, All showed only a com­
plex I deficiency in their muscle tissue (Bentlage, 
unpublished results). This illustrates the uniqueness 
of the case presented here.
Robinson et a l.23 reported a complex I deficiency in
246 NEUROLOGY 47 July 1996




subjects^ N - 8
NADH:Q:
oxidoreductase
0.05 (39) 0.13 ± 0.03 0.10--0.20
Succinate:cytochrome c 
oxidoreductase




1.87 (98) 1.90 ± 0.31 1.56--2.61
Cytochrome c oxidase 0.78 (92) 0.85 ±  0.13 0.68--1.05
Cytochrome c oxidase§ 0.63 (91) 0.69 ± 0.11 0.54-0.89
CS (mU/mg protein) 203 (90) 226 ± 23 189--257
* Expressed in mU * mU“ 1 CS. 
t  Percent of mean of controls.
$ Values are means ± SD.
§ In whole cell homogenate.
fibroblasts of four patients with the clinical picture 
of LIMD. Three patients had signs of CNS involve­
ment such as hypertonia, seizures, and an abnormal 
EEG. Unfortunately, they did not mention the bio­
chemical investigation of muscle tissue; thus, it is 
unclear whether these patients also had a combined 
complex I and IV defect in their muscle.
A unique Chinese hamster m utant lung cell line, 
Gal 32, also exhibits extremely low activities of both 
complex I and IV at moderately decreased activities 
of other respiratory chain complexes.24 Simultaneous 
correction of this pleiotropic phenotype in a sponta­
neous revertant suggested the presence of a single 
nDNA mutation in Gal 32.25 Mitochondrial protein 
synthesis revealed low amounts of mtDNA encoded 
complex I and IV subunits in this cell line, whereas 
the amounts of mitochondrial RNAs were increased 
but of correct size. Therefore, a mutation altering 
mitochondrial tRNA structure or base modification 
was assumed,26 However, our patient had normal 
biosynthesis of all mitochondrial translation prod­
ucts in his fibroblasts, despite the reduced complex I 
activity. Thus, the phenotype of our patient probably 
arose from a different mutation.
In humans, there are tissue-specific isoforms of 
subunits Via27 and V ila28 of complex IV, a heart (H) 
and liver (L) form. In human heart, there are equal 
amounts of H- and L-forms, whereas in skeletal mus­
cle there is mainly thè H-form.27”30 The L-form is 
exclusively present in liver, brain, kidney, smooth 
muscle,30 and in cultured fibroblasts31 and myo­
blasts .32 During myogenesis32 and during fetal devel­
opment,33 both subunits switch from L-type to 13- 
type in human heart and skeletal muscle. Complex I 
possibly also has isoforms,34>35 but there are no data 
at the molecular level yet. A mutation in one of the 
H-type subunit isoforms of COX would account for 
the normal fetal development (L-form) and the heter­
ogeneous tissue expression of the complex IV defect 
in the presented patient, that is, normal activity in
:lì>ÌW(WrtWSljW!iUJjlV.
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